Welcome to the Emerging and Pandemic Infections Consortium

Welcome to EPIC – the Emerging and Pandemic Infections Consortium.

EPIC partners play an integral role in infectious disease research, from work that controlled diphtheria and helped eradicate smallpox 100 years ago, to current research in antimicrobial resistance and infection control. 

Today, our collective fight against infectious threats, including COVID-19, highly pathogenic avian influenza and mpox, makes clear that there’s never been a more important time to advance EPIC – the Emerging and Pandemic Infections Consortium as a critical hub in the pan-Canadian effort to combat future pandemics.  

Building on our momentum in combatting the SARS-CoV-2 virus, EPIC will marshal the advanced research infrastructure and the world-renowned research and training expertise of the EPIC partners to allow an integrated innovative response to infectious diseases.

 

      EPIC is a collaborative initiative among:

      • University of Toronto
      • The Hospital for Sick Children (SickKids) 
      • Lunenfeld-Tanenbaum Research Institute
      • Sunnybrook Research Institute
      • University Health Network
      • Unity Health Toronto

      These globally-leading institutions will make a difference to preventing the next pandemic and enhancing the impact of the life sciences ecosystem in Ontario. 

      These are the four pillars of EPIC’s work

      Toronto High Containment Facility

      Toronto’s only Combined Containment Level 3 (C-CL3) facility for the study of high-risk human pathogens has been critical to understanding the viral pathogens and developing therapeutics and treatments.  Infectious diseases continue to pose a threat to Canadians’ health and prosperity. Investments in the facility will prepare Ontario and Canada for future pandemics.

      Training & Talent

      EPIC offers immersive and cross-disciplinary training  to a diverse cohort of talent researching infectious diseases, who are ready to work in industry and academia. Hundreds of researchers, clinicians and lab staff will gain access to leading-edge technologies, develop the skills to turn discovery into solutions, and connect Canada to global networks of pandemic surveillance and response.   

      Icon on Miscroscope

      Transformative Research

      EPIC will connect multiple disciplines to address infectious diseases. Insights made possible by state-of-the-art platforms that accelerate the discovery and production of therapies will combine with the expertise of clinicians, engineers,public health experts  and scientists to translate treatments to patients and improve their outcomes.  

      Icon of Network Connections

      Knowledge Translation

      EPIC will play an important role as a knowledge broker. It will create a hub for potential commercialization of novel therapeutics. New researchers at EPIC will be equipped to explain bench science to decision-makers and the public, as well as to translate discoveries into made-in-Canada products and solutions  to global health challenges.   

      EPIC News

      U of T study uncovers how a new gut microbe drives the gut-lung axis

      U of T study uncovers how a new gut microbe drives the gut-lung axis

      University of Toronto professor Arthur Mortha (right) and former postdoctoral fellow Kyle Burrows December 19, 2024 By Betty Zou A team led by University of Toronto researchers has discovered a new communication pathway between the gut and lung. Their findings...

      EPIC welcomes the third cohort of the Doctoral Awards recipients

      EPIC welcomes the third cohort of the Doctoral Awards recipients

      Top row (left to right): Shana Alexander, Omri Arbiv, Yami Ommar Arizmendi Cardenas, Ali Barzegar Khanghah, Justin Callahan, Deepa Chaphekar. Second row (left to right): Yu Ying Fan, Mohammadamir Ghasemian Moghaddam, Sumiha Karunagaran, Pranamika Khayargoli, Dongyeob...

      Upcoming Events